Every year, World Pneumonia Day 2025 is observed on November 11 around the globe to raise awareness about the respiratory ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

A pulmonologist at the Cleveland Clinic shares the lung cancer warning signs he looks for in his own body. The deadly disease ...

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...

The company said it is discontinuing the phase 3 ICoN-1 clinical trial evaluating MNKD-101 which aimed to treat refractory nontuberculous mycobacterial lung disease, a persistent, hard-to-treat lung ...

November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to ...

Dave Nitsche, a nonsmoker and athlete, was diagnosed with stage 4 lung cancer after vision loss led to the discovery of ...

MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Finger clubbing, a change in nail shape and fingertip swelling, can be an early indicator of lung cancer, though it often appears in later stages. This condition, characterized by curved nails and ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown ...